Home > Articles > Published articles > An analysis of patient-reported outcomes in ixora-s : > Comments
 
 
An analysis of patient-reported outcomes in ixora-s : Comparing ixekizumab and ustekinumab over 52 weeks in moderate-to-severe psoriasis - Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Lomaga, Mark (DermEdge Research and Probity Medical Research) ; Hollister, Kristin (Eli Lilly and Company) ; Dutronc, Yves (Eli Lilly and Company) ; Berggren, Lovisa (HaaPACS GmbH) ; Van De Kerkhof, Peter C.M. (Radboud University Nijmegen Medical Centre) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>

Similar records

UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with